UNH vs ELV
UNH and ELV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | ELVELEVANCE HEALTH, INC. |
|---|---|---|
| Market cap | $338.66B | $90.08B |
| P/E (TTM) | 24.2 | 18.4 |
| P/B | 10.26 | 2.01 |
| P/S | 0.8x | 0.5x |
| Dividend yield | 2.34% | 1.70% |
| Revenue | $450.13B(TTM) | $201.11B(TTM) |
| Revenue growth (YoY) | 11.8% | 12.5% |
| Net income | $14.12B(TTM) | $4.96B(TTM) |
| Earnings growth (YoY) | -16.3% | -5.3% |
| EPS, diluted | $15.56(TTM) | $22.61(TTM) |
| EBIT margin | 4.2% | 3.6% |
| ROE | 36.5% | 12.6% |
| ROIC | 21.3% | 9.3% |
| 1y total return | +12.9% | +37.1% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: UNH frente a ELV
| Métrica | UNH | ELV |
|---|---|---|
| Valor final | $34.4K | $35.1K |
| Retorno total | +244.3% | +251.3% |
| CAGR | +12.7% | +12.9% |
| Volatilidad | 29.9% | 31.0% |
| Sharpe | 0.41 | 0.42 |
| Sortino | 0.57 | 0.59 |
| Caída máxima | -61.4% | -50.4% |
Basado en 2600 días de negociación comunes, 2016-05-16 → 2026-09-17 · tasa libre de riesgo 4.14% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)